PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23652045-2	2013	The aim of this study was to investigate the effects of TAP on antihyperglycemic, antioxidant, and pancreas-protective in streptozotozin (STZ)-diabetic rats.	streptozotozin	122-136	nuclear RNA export factor 1	Rattus norvegicus	56-59
25093193-5	2014	In the current study, we recorded the spontaneous firing of neurons in hippocampal CA1 area in anesthetized streptozotozin (STZ)-diabetic and age-matched control rats.	streptozotozin	108-122	carbonic anhydrase 1	Rattus norvegicus	83-86
28768549-4	2017	METHODS: Therefore, we have analyzed the central long-term complications in the offspring from CD1 diabetic mothers treated with streptozotozin, as well as the possible reversion of these alterations by insulin administration to neonates.	streptozotozin	129-143	CD1c molecule	Homo sapiens	95-98
23318573-2	2013	Herein, in low-density lipoprotein receptor-deficient hyperlipidemic and streptozotozin-induced diabetic mice, hyperglycemia and hyperlipidemia acted reciprocally, accentuating renal injury and altering renal function.	streptozotozin	73-87	low density lipoprotein receptor	Mus musculus	11-43
23745546-6	2013	Recently, first evidence that the topical administration of SST prevents retinal neurodegeneration in streptozotozin- induced diabetic rats has been reported.	streptozotozin	102-116	somatostatin	Rattus norvegicus	60-63
20621835-2	2010	Given that the Wnt/beta-catenin pathway is a major regulator of bone accrual, we assessed this pathway in mice with streptozotozin-induced T1D.	streptozotozin	116-130	catenin (cadherin associated protein), beta 1	Mus musculus	19-31
16731816-6	2006	After streptozotozin (STZ) administration of double-transgenic mice, a synergic action in skeletal muscle between the insulin produced and the increased glucose phosphorylation by glucokinase was established, preventing hyperglycemia and metabolic alterations.	streptozotozin	6-20	insulin	Homo sapiens	118-125
16753349-3	2006	In high-fat diet-fed and low-dose streptozotozin-treated diabetic Wistar rats subjected to challenge with exogenous human insulin, AC treatment at an oral dose of 0.40 g/kg could significantly improve sensitivity to exogenous insulin.	streptozotozin	34-48	insulin	Homo sapiens	122-129
16753349-3	2006	In high-fat diet-fed and low-dose streptozotozin-treated diabetic Wistar rats subjected to challenge with exogenous human insulin, AC treatment at an oral dose of 0.40 g/kg could significantly improve sensitivity to exogenous insulin.	streptozotozin	34-48	insulin	Homo sapiens	226-233
16753349-4	2006	After a sub-acute treatment, AC also could inhibit the development of insulin resistance in high-fat diet-fed and low-dose streptozotozin-treated diabetic rats following the test of loss of tolbutamide-induced blood glucose lowering action.	streptozotozin	123-137	insulin	Homo sapiens	70-77
16731816-6	2006	After streptozotozin (STZ) administration of double-transgenic mice, a synergic action in skeletal muscle between the insulin produced and the increased glucose phosphorylation by glucokinase was established, preventing hyperglycemia and metabolic alterations.	streptozotozin	6-20	glucokinase	Mus musculus	180-191
14618236-3	2004	METHODS: mRNA and protein expression of Abcg5 and Abcg8 were determined in the liver and intestine of rats with streptozotozin-induced diabetes and related to relevant metabolic parameters in plasma, liver and bile.	streptozotozin	112-126	ATP binding cassette subfamily G member 5	Rattus norvegicus	40-45
16783882-10	2006	Collectively, these results indicate that the renal PTHrP/PTH1R system is upregulated in streptozotozin-induced diabetes in mice, and appears to adversely affect the outcome of diabetic renal disease.	streptozotozin	89-103	parathyroid hormone-like peptide	Mus musculus	52-57
16783882-10	2006	Collectively, these results indicate that the renal PTHrP/PTH1R system is upregulated in streptozotozin-induced diabetes in mice, and appears to adversely affect the outcome of diabetic renal disease.	streptozotozin	89-103	parathyroid hormone 1 receptor	Mus musculus	58-63
14618236-3	2004	METHODS: mRNA and protein expression of Abcg5 and Abcg8 were determined in the liver and intestine of rats with streptozotozin-induced diabetes and related to relevant metabolic parameters in plasma, liver and bile.	streptozotozin	112-126	ATP binding cassette subfamily G member 8	Rattus norvegicus	50-55
9642333-1	1997	OBJECTIVE: To demonstrate the hypoglycemic effects and translocation of glucose transporter (Glut 1 and Glut 4) promoted by peroxovanadate and nicotinic acid complexes (nicotinic chelated bitriperoxovanadate, POR; N-O nicotinic chelated peroxovanadate, POV) in streptozotozin-induced diabetic rats.	streptozotozin	261-275	solute carrier family 2 member 1	Rattus norvegicus	93-99
9642333-1	1997	OBJECTIVE: To demonstrate the hypoglycemic effects and translocation of glucose transporter (Glut 1 and Glut 4) promoted by peroxovanadate and nicotinic acid complexes (nicotinic chelated bitriperoxovanadate, POR; N-O nicotinic chelated peroxovanadate, POV) in streptozotozin-induced diabetic rats.	streptozotozin	261-275	solute carrier family 2 member 4	Rattus norvegicus	104-110